ENTRAR            

 


 

PARANINFO DIGITAL INDEX

 

 

 

 

 

 

 

 

 

Comentar este texto

Ir a Sumario

Documento anterior

Documento siguiente

Enviar correo al autor

Sin Ttulo


Modalidad de presentación:
comunicación digital

 

REF.: 172d

¿Y por qué no usar Essure como método anticonceptivo?
Miriam Abdel Karim Ruiz,1 María Hernández Rabal,2 Mª Gloria Barranco Berrocal2
(1) Hospital Costa del Sol. Marbella (Málaga), España. (2) Hospital Regional Universitario Carlos Haya. Málaga, España

Rev Paraninfo digital, 2013: 19

Cómo citar este documento
Abdel Karim Ruiz, Miriam; Hernández Rabal, María; Barranco Berrocal, Mª Gloria. ¿Y por qué no usar Essure como método anticonceptivo? Rev Paraninfo Digital, 2013; 19. Disponible en: <http://www.index-f.com/para/n19/172d.php> Consultado el 26 de Mayo del 2022

RESUMEN

Introducción: Essure es un dispositivo de acero inoxidable, que al ser introducido en la trompa de Falopio induce a una respuesta inflamatoria, lo que resulta en un bloqueo gradual y de forma permanente. Es una alternativa muy interesante a la vasectomía y a la obstrucción tubárica por laparoscópica. Asociada a un postoperatorio inmediato por no necesitar incisiones ni anestesia, disminución de dolor, mejor tolerancia por el paciente y a una reducción de estancia en el hospital.
Objetivo: Evaluar el procedimiento, colocación y evolución de la esterilización intratubárica mediante este dispositivo.
Metodología: Se realizó una búsqueda bibliográfica en bases de datos como Cochrane Plus, Medline, Gerion, SciELO, Cuiden.
Resultados: Los estudios muestran que es un método de esterilización ambulatoria, sin anestesia. Exitoso, seguro y asociado a una alta satisfacción. Aunque también tiene sus complicaciones.
Discusión: Los profesionales sanitarios debemos conocer las alternativas anticonceptivas disponibles en la actualidad, con el fin de poder asesorar eficazmente.
Palabras clave: Essure/ Histeroscopia/ Esterilización tubárica.
 

ABSTRACT
And why not use Essure for contraception?

Introduction: Essure device is stainless steel, which when inserted into the fallopian tube to induce an inflammatory response, resulting in gradual blockage and permanently. It is a very interesting alternative to vasectomy and tubal obstruction by laparoscopy. Associated with postoperative need not incisions or anesthesia, decreased pain, better patient tolerance and reduced hospital stay.
Objective: To evaluate the procedure, placement and evolution of intra sterilization through this device.
Methods: We performed a literature search in databases such as Cochrane, Medline, Gerion, SciELO, Cuiden.
Results: Studies show that a method of sterilization is ambulatory without anesthesia. Successful, safe and associated with high satisfaction. But it also has its complications.
Discussion: Clinicians must know the contraceptive choices available today, in order to effectively advise.
Key-words: Essure/ Hysteroscopy/ Tubal sterilization.

Bibliografía

1. Royal Australasian College of Surgeons. New and Emerging Techniques-Surgical Horizon Scanning Report 2004. Essure� System for Tubal Sterilization. Disponible en: http://www.surgeons.org/AM/Template.cfm?Section=Home&Template=/CM/ContentDisplay.cfm&ContentFileID=1820
2. Kerin JF, Cooper JM, Price T, Van Herendael B, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod. 2003 Jun;18(6):1223-30.
3. Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert Nonincisional Hysteroscopic Sterilization. Obstet Gynecol. 2003 Jul; 102 (1):59-67.
4. Legendre G, Levaillant JM, Faivre E, Deffieux X, Gervaise A, Fernandez H. 3D ultrasound to assess the position of tubal sterilization microinserts. Hum Reprod. 2011 Oct; 26(10):2683-9.
5. Castaño PM, Adekunle L. Transcervical sterilization. Semin Reprod Med. 2010 Mar; 28(2):103-9.
6. Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril. 2010 Jan; 93(1):29-34.
7. Palomo Viciana M.J., Quesada Hurtado J., Camacho Caro M., Sánchez Sánchez E., Cóndor Muñoz L.M. Essure, nuevo método de planificación familiar. Nuestra experiencia en un año en el Hospital Universitario Virgen de la Victoria. Málaga. Análisis descriptivo. Toko - Gin Pract, 2013; 72(3):82-88.
8. Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol. 2005 Jul-Aug; 12(4):318-22.
9. Hopkins MR, Creedon DJ, Wagie AE, Williams AR, Famuyide AO. Retrospective cost analyses comparin Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation.  J Minim Invasive Gynecol. 2007 Jan-Feb; 14(1):97-102.
10. Palmer MD, Greenberg MD. Transcervical sterilization: a comparison of essure(r) permanent birth control system and adiana(r) permanent contraception system. Rev Obstet Gynecol. 2009 Spring; 2(2):84-92.
11. Povedano B, Arjona JE, Velasco E, Monserrat JA, Lorente J, Castelo-Branco C. Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre. BJOG. 2012 Jun; 119(7):795-9.
12. Wittmer MH, Brown DL, Hartman RP, Famuyide AO, Kawashima A, King BF. Sonography, CT, and MRI appearance of the Essure microinsert permanent birth control device. AJR Am J Roentgenol. 2006 Oct; 187(4):959-64.
13. Duffy S, Marsh F, Rogerson L, Hudson H, Cooper K, Jack S, et al. Female sterilisation: a cohort controlled comparative study of Essure versus laparoscopic sterilisation. BJOG. 2005 Nov; 112(11):1522-8.
14. Connor VF. Essure: a review sis years later. J Minim Invasive Gynecol. 2009 May-Jun; 16(3):282-90.
15. Famuyide AO, Hopkins MR, El-Nashar SA, Creedon DJ, Vasdev GM, Driscoll DJ, et al. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008 Apr; 83(4):431-8.
16. Kevin JF, Carigan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study. Aust N Z J Obstet Gynaecol. 2001 Nov;41(4):364-70.
17. Shavell VI, Abdallah ME, Shade GH Jr, Diamond MP, Berman JM. Trends in sterilization since the introduction of Essure hysteroscopic sterilization. J Minim Invasive Gynecol. 2009 Jan-Feb; 16(1):22-7.
18. Úbeda A, Labastida R, Dexeus S. Essure: A new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril. 2004 Jul;82(1):196-9.
19. Belotte J, Shavell VI, Awonuga AO, Diamond MP, Berman JM, Yancy AF. Small bowel obstruction subsequent to Essure microinsert sterilization: a case report. Fertil Steril. 2011 Jul; 96(1):e4-6.
20. Moawad N, Mansuria S. Essure perforation and chronic pelvic pain. J Minim Invasive Gynecol. 2011 May-Jun; 18(3):285-6.
21. Thoma V, Chua I, Garbin O, Hummel M, Wattiez A. Tubal perforation by ESSURE microinsert. J Minim Invasive Gynecol. 2006 Mar-Apr; 13 (2):161-3.
22. Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure placement: report of two cases Fertil Steril. 2008 Mar;89(3):724.e9-11.
23. Hastings-Tolsma M, Nodine P, Teal SB, Embry J. Pregnancy outcome after transcervical hysteroscopic sterilization. Obstet Gynecol. 2007 Aug;110(2 Pt 2):504-6.
24. Hur HC, Mansuria SM, Chen BA, Lee TT. Laparoscopic management of hysteroscopic Essure sterilization complications: report of 3 cases. J Minim Invasive Gynecol. 2008 May-Jun; 15(3):362-5.
25. Veersema S, Vleugels MP, Moolenaar LM, Janssen CA, Brölmann HA. Unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril. 2010 Jan; 93(1):35-8.
26. Jain P, Clark TJ. Removal of Essure® device 4 years post-procedure: a rare case. J Obstet Gynaecol. 2011; 31(3):271-2.
27. Mijatovic V, Dreyer K, Emanuel MH, Schats R, Hompes PG. Essure® hydrosalpinx occlusion prior to IVF-ET as an alternative to laparoscopic salpingectomy. Eur J Obstet Gynecol Reprod Biol. 2012 Mar; 161(1):42-5.
28. Thébault N, Broux PL, Moy L, Vialard J. Utilization of Essure® micro-insert for hydrosalpynx occlusion in infertile women. Gynecol Obstet Biol Reprod (Paris). 2012 Apr; 41(2):145-50.
29. Fernandez H. Update on the management of menometrorrhagia: new surgical approaches. Gynecol Endocrinol. 2012 Feb; 28(2):156.
30. Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet. 2007 May; 97(2):139-42.
31. Theroux R.The hysteroscopic approach to sterilization. J Obstet Gynecol Neonatal Nurs. 2008 May-Jun; 37(3):356-60.

Principio de p᧩na
error on connection